×
About 4,948 results

ALLMedicine™ Rabies Center

Research & Reviews  1,704 results

One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell ...
https://doi.org/10.1016/j.vaccine.2022.07.037
Vaccine Quiambao BP, Lim JG et. al.

Aug 7th, 2022 - Shorter rabies pre-exposure prophylaxis (PrEP) regimens may offer improved convenience and feasibility over classic 3-week regimens, for example in regions with poor access to vaccines or for travelers to rabies-endemic regions. In this multicente...

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults
https://clinicaltrials.gov/ct2/show/NCT04062669

Aug 5th, 2022 - The purpose of this first time-in-human (FTiH) study is to evaluate the safety, reactogenicity and immunogenicity of different dose levels of an experimental rabies glycoprotein G (RG) vaccine (RG-SAM [CNE] vaccine), made using a new technology, w...

Perception of canine rabies among pupils under 15 years in Kwara State, North Central N...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348711
PLoS Neglected Tropical Diseases; Al-Mustapha AI, Bamidele FO et. al.

Aug 4th, 2022 - Rabies is an endemic, highly fatal, and vaccine-preventable disease with severe socio-economic implications. Most (99%) human rabies cases are transmitted through dog bites. Children under 15 years account for 40% of all dog bite victims and 35-50...

Evolutionary analysis of rabies virus isolates from Georgia.
https://doi.org/10.1007/s00705-022-05550-3
Archives of Virology; Tabatadze L, Gabashvili E et. al.

Aug 2nd, 2022 - Genetic relationships between rabies virus (RABV) isolates recovered from dogs, jackals, and cattle in Georgia and their closest relatives were investigated by comparing their nucleoprotein (N) gene sequences. Multiple isolates from dogs and cattl...

Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects
https://clinicaltrials.gov/ct2/show/NCT04019444

Aug 1st, 2022 - This is a single-center, observer-blinded, Phase 1, dosage-escalation trial to evaluate the safety, tolerability, reactogenicity, and immunogenicity of ChAd155-RG compared with RABAVERT in rabies virus-naïve healthy male and non-pregnant female ad...

see more →

Guidelines  1 results

Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent huma...
https://doi.org/10.1016/j.annemergmed.2010.05.020
Annals of Emergency Medicine;

Jul 22nd, 2010 - Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies-recommendations of the Advisory Committee on Immunization Practice.|2010| ,|immunology,immunology,prevention & control,administration & dosage,adverse ...

see more →

Drugs  12 results see all →

Clinicaltrials.gov  119 results

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults
https://clinicaltrials.gov/ct2/show/NCT04062669

Aug 5th, 2022 - The purpose of this first time-in-human (FTiH) study is to evaluate the safety, reactogenicity and immunogenicity of different dose levels of an experimental rabies glycoprotein G (RG) vaccine (RG-SAM [CNE] vaccine), made using a new technology, w...

Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects
https://clinicaltrials.gov/ct2/show/NCT04019444

Aug 1st, 2022 - This is a single-center, observer-blinded, Phase 1, dosage-escalation trial to evaluate the safety, tolerability, reactogenicity, and immunogenicity of ChAd155-RG compared with RABAVERT in rabies virus-naïve healthy male and non-pregnant female ad...

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine
https://clinicaltrials.gov/ct2/show/NCT05453487

Jul 29th, 2022 - The participants aged ≥18 who had received two doses of inactivated COVID-19 vaccine were recruited and randomly assigned to one of three study groups: Co-Ad group, COVID-19 vaccine group and Rabies vaccine group. The participants in Co-Ad group a...

Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali
https://clinicaltrials.gov/ct2/show/NCT05135273

Jul 20th, 2022 - A vaccine to interrupt malaria transmission (VIMT), targeting disruption of parasite transmission through both human and mosquito, would be a valuable additional resource in the fight to eliminate this disease. Transmission-blocking vaccines (TBVs...

Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults
https://clinicaltrials.gov/ct2/show/NCT03965962

Jul 19th, 2022 - Study duration per participant was approximately 7 months including: 1 day of screening and vaccination, a total of 5 vaccine injections over a 28-day period, 1 safety-follow up visit at Day 42, 1 safety follow-up/end of study visit at Day 56 and ...

see more →

News  137 results

Human Rabies in Brazil: A Warning of Epidemiological Changes
https://www.medscape.com/viewarticle/978120

Jul 27th, 2022 - Until 2022, there hadn't been a case of human rabies recorded in the Federal District of Brazil for 44 years. And already to date, there have been five cases nationwide: one teenager in Brasília and, according to the Ministry of Health, four in Mi...

GSK, Novartis Pledge Funds for Neglected Tropical Diseases
https://www.medscape.com/viewarticle/976095

Jun 24th, 2022 - LONDON (Reuters) - GSK and Novartis reinforced commitments on Thursday to tackle neglected tropical diseases, as world leaders and health experts gather in Rwanda to discuss ways to better combat illnesses affecting more than a billion people, mos...

Update on Rabies, TBE, and Cholera Vaccines Before Travel
https://www.medscape.com/viewarticle/974443

May 27th, 2022 - Healthcare providers should be aware of important updates to vaccine recommendations that could affect patients preparing to travel internationally this summer. This includes information about: New rabies pre-exposure prophylaxis guidelines (PrEP)...

Rabies: CDC Updates and Simplifies Preexposure Prophylaxis Vaccination Recommendations
https://www.medscape.com/viewarticle/974298

May 19th, 2022 - Each year, there are about 59,000 deaths from rabies globally. Most of these occur outside the United States and are the result of dog bites. Since infection with rabies is almost always fatal, there has been considerable attention given to vaccin...

Cats, toxoplasmosis, and psychosis: Understanding the risks
https://www.mdedge.com/psychiatry/article/254207/schizophrenia-other-psychotic-disorders/cats-toxoplasmosis-and-psychosis
E. Fuller Torrey, MD

May 2nd, 2022 - It has been clearly established that most human infectious diseases are caused by infectious agents that have been transmitted from animals to humans. 1 Based on published estimates from the 2000s, 60% to 76% of emerging infectious disease events a.

see more →

Patient Education  6 results see all →